検索結果 - Gwo Fuang Ho

  • 検索結果 1 - 16 結果 / 16
結果の絞り込み
  1. 1
    The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial

    The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial 著者: Raghib Ali, Gwo Fuang Ho, Whay-Kuang Chia

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)

    Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlle... 著者: Andrew J.S. Coats, Gwo Fuang Ho, Kumar Prabhash, Stephan von Haehling, Julia Tilson, R. H. Brown, John Beadle, Stefan D. Anker

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Robot-assisted radiofrequency ablation of primary and secondary liver tumours: early experience

    Robot-assisted radiofrequency ablation of primary and secondary liver tumours: early experience 著者: Basri Johan Jeet Abdullah, Chai Hong Yeong, Khean‐Lee Goh, Boon Koon Yoong, Gwo Fuang Ho, Carolyn Chue Wai Yim, Anjali Kulkarni

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    The Predictive Accuracy of PREDICT

    The Predictive Accuracy of PREDICT 著者: Hoong-Seam Wong, Shridevi Subramaniam, Z. Alias, Nur Aishah Mohd Taib, Gwo Fuang Ho, Char‐Hong Ng, Cheng Har Yip, Helena M. Verkooijen, Mikael Hartman, Nirmala Bhoo‐Pathy

    出版事項 2015
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients

    Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients 著者: Nirmala Bhoo‐Pathy, Cheng Har Yip, Mikael Hartman, Nakul Saxena, Nur Aishah Mohd Taib, Gwo Fuang Ho, Lai‐Meng Looi, Awang Bulgiba, Yolanda van der Graaf, Helena M. Verkooijen

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

    The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia re... 著者: Andrew J.S. Coats, Venkatesan Srinivasan, J Surendran, Haritha Chiramana, S. Vangipuram, Nirajkumar N. Bhatt, Minish Jain, Sandip Shah, Imran Ali, Gwo Fuang Ho, Mohammed Z. M. Hassan, John Beadle, Julia Tilson, Bridget‐Anne Kirwan, Stefan D. Anker

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial

    Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial 著者: Shukui Qin, Zhendong Chen, Weijia Fang, Zhenggang Ren, Ruocai Xu, Baek‐Yeol Ryoo, Zhiqiang Meng, Yuxian Bai, Xiaohong Chen, Xiufeng Liu, Juxiang Xiao, Gwo Fuang Ho, Yimin Mao, Xin Wang, Jieer Ying, Jianfeng Li, Wenyan Zhong, Yu Zhou, Abby B. Siegel, Chunyi Hao

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

    Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma 著者: Whay-Kuang Chia, Marissa Teo, Who-Whong Wang, Bernett Lee, Soo-Fan Ang, Wai-Meng Tai, Chit-Lai Chee, Joanna Ng, Rebecca Kan, Wan‐Teck Lim, Sze Huey Tan, Whee-Sze Ong, Yin‐Bun Cheung, Eng-Huat Tan, John E. Connolly, Stephen Gottschalk, Gwo Fuang Ho

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

    Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial 著者: Călin Căinap, Shukui Qin, Wen‐Tsung Huang, Ik Joo Chung, Hongming Pan, Ying Cheng, Masatoshi Kudo, Yoon‐Koo Kang, Pei‐Jer Chen, Gwo Fuang Ho, Vera Gorbunova, Ferry A.L.M. Eskens, Jiang Qian, Mark D. McKee, Justin L. Ricker, Dawn M. Carlson, Saied El-Nowiem

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline

    Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline 著者: Gilberto Lopes, Mariana C. Stern, Sarah Temin, Ala I. Sharara, Andrés Cervantes, Ainhoa Costas‐Chavarri, R. Engineer, Chisato Hamashima, Gwo Fuang Ho, Fidel David Huitzil, Mona Malekzadeh, Govind Nandakumar, Manish A. Shah, Catherine Teh, Sara E. Vázquez Manjarrez, Azmina Verjee, Rhonda K. Yantiss, Marcia Cruz Correa

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

    Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study 著者: Gwo Fuang Ho, Chee-Shee Chai, Adlinda Alip, Mohd Ibrahim A. Wahid, Matin Mellor Abdullah, Y.C. Foo, Soon-Hin How, Adel Zaatar, Kai-Seng Lam, Kin-Wah Leong, John-Seng-Hooi Low, Mastura Md Yusof, Erica Chai-Yong Lee, Yok-Yong Toh, Chong Kin Liam

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline

    Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline 著者: Ainhoa Costas‐Chavarri, Govind Nandakumar, Sarah Temin, Gilberto Lopes, Andrés Cervantes, Marcia Cruz Correa, R. Engineer, Chisato Hamashima, Gwo Fuang Ho, Fidel David Huitzil, Mona Malekzadeh, Ala I. Sharara, Mariana C. Stern, Catherine Teh, Sara E. Vázquez Manjarrez, Azmina Verjee, Rhonda K. Yantiss, Manish A. Shah

    出版事項 2019
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC

    Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC 著者: Wan Ling Tan, Kevin Lee Min Chua, Chia‐Chi Lin, Victor Lee, Lye Mun Tho, Anthony W.H. Chan, Gwo Fuang Ho, Thanyanan Reungwetwattana, James Chih‐Hsin Yang, Dong‐Wan Kim, Ross A. Soo, Yong Chan Ahn, Hiroshi Onishi, Myung‐Ju Ahn, Tony Mok, Daniel S.W. Tan, Fan Yang

    出版事項 2019
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  14. 14
    Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC with PD-L1 Expression ≥50%: 5-Year Outcomes of EMPOWER-Lung 1

    Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC with PD-L1 Expression ≥50%: 5-Year Outcomes of EMPOWER-Lung 1 著者: Saadettin Kılıçkap, Ana Baramidze, Ahmet Sezer, Mustafa Özgüroğlu, Mahmut Gumus, Igor Bondarenko, Miranda Gogishvili, Marina Nechaeva, Michael Schenker, İrfan Çiçin, Gwo Fuang Ho, Yaroslav Kulyaba, Kasimova Zyuhal, Roxana-Ioana Scheusan, Marina Chiara Garassino, Yuntong Li, Cong Zhu, M. Kaul, Javier J. Pérez, Frank Seebach, Israel Lowy, Jean‐François Pouliot, Ki Dong Kim, Heather Magnan

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

    Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed... 著者: L.-T. Chen, Erika Martinelli, Ann‐Lii Cheng, George Pentheroudakis, Si-bei Qin, G.S. Bhattacharyya, Masafumi Ikeda, Ho Yeong Lim, Gwo Fuang Ho, Su Pin Choo, Zhenggang Ren, Hemant Malhotra, Makoto Ueno, Baek‐Yeol Ryoo, Tina Kiang, David Tai, Arndt Vogel, Andrés Cervantes, Sheng‐Nan Lu, Chung‐Jen Yen, Yi‐Hsiang Huang, San‐Chi Chen, Chiun Hsu, Ying‐Chun Shen, Josep Tabernero, Yun Yen, Chih‐Hung Hsu, Takayuki Yoshino, J.-Y. Douillard

    出版事項 2020
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

    Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial 著者: Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, Wan Qin Chong, S. B. Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Cheryl Ho, Mubashir Aziz, Quan Sing Ng, C-J. Yen, Nopadol Soparattanapaisarn, Roger KC Ngan, S.K. Kho, M.L.A. Tiambeng, Tak Yun, Virote Sriuranpong, Alain P. Algazi, Andy S. K. Cheng, Erminia Massarelli, Ramona F. Swaby, Sanatan Saraf, Jianda Yuan, Lillian L. Siu

    出版事項 2022
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: